Firms

Panakès Partners

Panakès Partners

Panakès Partners is a Milan-based venture capital manager investing in early-stage life-science startups and innovative SMEs, primarily in Europe. It finances therapeutic medicines, medical devices, diagnostics and healthcare technologies and supports scientific teams with business development and clinical and industrial networks. Its portfolio spans neuromodulation for tinnitus and migraine, Alzheimer diagnostics, robotic microsurgery, oncology and cardiovascular treatments. Its BII Catalyst Fund I for Italy supports early-stage Italian therapeutics companies in partnership with the BioInnovation Institute, Lazio Innova and Novo Holdings.

Founded
2015
Type
Venture capital

Funds1

  • BII Catalyst Fund I for Italy—

    First close announced on July 2, 2026 for an early-stage Italian therapeutics fund managed by Panakès Partners. Lazio Innova contributes EUR20 million through Lazio Venture 2 alongside Novo Holdings. The LP subsequently describes the total first close as exceeding EUR20 million; no exact fund total is asserted. BioInnovation Institute provides startup sourcing and access to its innovation platform, infrastructure and expertise. The fund supports translation of scientific discoveries into companies ready for later international financing.

Team

Operations and support

Alessio BeverinaFounder and Managing Partner
Alessio PiumaPrincipal
Andrea BalleriniInvestment Manager
Annalisa CoraducciSenior Analyst
Diana SaraceniFounder and Managing Partner
Fabrizio LandiFounder and Managing Partner
Federica PorcuFinancial Controller and ESG Manager
Giacomo PiccininiInvestment Manager
Lorenzo GiordanoChief Financial Officer
Marco SardinaScientific Partner
Michela BarcellaNetwork and Portfolio Talent Advisor
Paola CrovatoOffice and Deal Flow Manager
Simone ReAdvisor

Co-investing

Investments